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ABSTRACT
To study the role of endothelial factors in luteal function, the
dynamic profiles of genes for endothelin 1 (EDN1), its receptor
subtypes, EDNRA and EDNRB, and angiotensin converting
enzyme (ACE) were examined in corpora lutea (CL) obtained
from rabbits on Days 4 and 9 of pseudopregnancy after
prostaglandin (PG) F2a analogue (alfaprostol) treatment. The
cell type distribution of EDN1 in the ovaries and its mechanisms
of actions in vitro and in vivo were also studied. Positive
immunostaining for EDN1 was localized in the luteal and
endothelial cells, in granulosa cells of the follicles, and in the
ovarian epithelium. The basal mRNA levels for EDNRA, EDNRB,
and ACE were lower (P  0.01) in Day-4 CL than in Day-9 CL,
whereas those for EDN1 did not differ between these two time-
points. On Day 4, the luteal EDN1, EDNRA, EDNRB, and ACE
mRNA levels were similarly increased two-fold (P  0.01) 1.5 h
after alfaprostol injection, and did not show further changes in
the subsequent 24 h. On Day 9, alfaprostol challenge transiently
up-regulated (P  0.01) the luteal ACE transcripts at 1.5 h, and
those of EDN1 at 1.5 h and 3 h, whereas the EDNRA and EDNRB
transcript levels remained unchanged during the course of luteal
regression. EDN1 decreased (P  0.01) progesterone release and
increased (P  0.01) PGF2a secretion and NOS activity via the
PLC/PKC pathway in Day-9 CL, but not in Day-4 CL, cultured in
vitro. EDN1-induced, but not alfaprostol-induced luteolysis, was
blocked by cotreatment in vivo with the ACE antagonist
captopril. These findings support the hypothesis that PGF2a
regulates luteolysis through intraluteal activation of the renin-
angiotensin/EDN1 systems in CL that have acquired luteolytic
competence.
ACE, corpus luteum function, EDN1, EDNRA, EDNRB, luteolysis,
ovary
INTRODUCTION
Luteolysis is a streamlined process that involves functional
and structural changes that end with the complete demise of
corpora lutea (CL) through apoptotic pathways [1, 2]. In the
rabbit, which is a reflex ovulator, the luteolytic mechanism
comes into play either at the end of gestation or after an
infertile mating around Day 14 of pseudopregnancy [3]. In this
species, CL regression is driven by prostaglandin (PG) F2a
(PGF2a) of uterine origin [4], given that hysterectomy [5],
endometritis [6], and indomethacin treatment [7] prolong luteal
function.
Besides the key role of PGF2a, several distinct intraluteal
pathways have emerged as potential candidate mediators of its
luteolytic action [8]. Prominent among these mediators is
endothelin–1 (EDN1), a potent vasoconstrictor that is synthe-
sized by the vascular endothelium [9–11], which inhibits
progesterone release both in vivo and in vitro in a number of
species [12–15]. Recently, using the pseudopregnant rabbit
model in the mid-luteal stage, we have shown that the
luteolytic action of EDN1 is mediated by complex interactions
with the prostanoid cascade via its receptor subtype EDNRA;
for reasons that remain unclear, PGF2a does not require EDN1
to elicit its luteolytic effect [16].
An increasing body of evidence indicates that angiotensin
II (ANGII), which is the main effector of the renin-
angiotensin system (RAS) that regulates systemic blood
pressure and electrolyte balance, may act together with
EDN1 in the control of CL life-span [17, 18]. In fact, ANGII
is released by midcycle bovine CL in vitro and suppresses
progesterone release [19]. Moreover, all the components of
the RAS have been identified in the ovaries of rats and cows,
including renin and angiotensin I converting enzyme (ACE),
the enzymes that catalyze ANGI and ANGII production,
respectively, as well as the ANGII peptide and its receptor
[17, 20–26]. In addition, between PGF2a and both EDN1 and
ANGII, several modulated feedback and auto-amplifying
mechanisms have been described in the CL of ruminants
[27–29].
However, despite the extensive studies on luteal regression,
the physiological relevance of these vasoactive peptides in the
control of luteal function is still uncertain. Similarly, little is
known about which mechanisms protect the growing CL from
the functional luteolysis that occurs in the early luteal stage up
to Day 9 of pseudopregnancy, when the CL of rabbits shift
from refractoriness to complete responsiveness to exogenous
PGF2a [30, 31, 32] and EDN1 [16].
Therefore, the main objective of the present study was to
elucidate the basal and PGF2a analogue (alfaprostol)-induced
temporal expression changes for early luteal (Day-4) and
midluteal stage (Day-9) CL of pseudopregnancy, in order to
characterize the role of the EDN1/RAS system in the
acquisition of luteal sensitivity to PGF2a. In addition, using
in vivo and in vitro studies, we further investigated the
luteolytic mechanisms of action of EDN1.
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MATERIALS AND METHODS
Reagents
Primers for the mRNAs of EDN1, EDNRA, EDNRB, and ACE, random
hexamer primers, DNAase I, RNAse H-reverse transcriptase (Superscript II), E.
coli RNase H, DNA molecular mass ladders, TRIzol, Taq DNA polymerase
(Platinum), 103 PCR Buffer, 50 mM MgCl
2
, RNAse-free tubes, RNAse-free
water, and deoxy-NTPs were obtained from Invitrogen (S. Giuliano Milanese,
Milan, Italy). Primers for 18S rRNA and the corresponding competimers
(QuantumRNA 18S Internal Standards) were acquired from Ambion (Austin,
TX). Tritiated hormones and [2,3–3H]L-arginine, with a specific activity of 30–
40 Ci/mmol, were purchased from Amersham Biosciences (Amersham
Biosciences Ltd., Little Chalfont, Bucks, UK), while progesterone and PGF2a
antisera and nonradioactive hormones were from Sigma (St Louis, MO). The
NOS Detect Assay Kit was purchased from Alexis Corp. (La¨ufelfingen,
Switzerland). The primary mouse monoclonal anti-EDN1 antibody, which was
used for immunohistochemistry, was supplied by ABR Affinity Bioreagents
(Golden, CO). The biotinylated secondary antibody, goat anti-mouse IgG, was
purchased from Vector Laboratories (Burlingame, CA). The avidin-biotin
complex (ABC, Vector Elite Kit) and the chromogen 3,30-diaminobenzidine
tetrachloride (DAB) were also from Vector Laboratories. The kit for protein
assays was purchased from Bio-Rad Laboratories (Hercules, CA).
Incubation wells were obtained from Becton Dickinson (Clifton, NJ),
medium 199 and Earles Balanced Salt Solution (EBSS) were from GIBCO
(Grand Island, NY). Phospholipase A2 (PLA
2
, 4-bromophenacyl bromide),
PLC (compound 4880), PKC (staurosporine), ACE (captopril) inhibitors,
Hepes, and BSA were purchased from Sigma, whereas all other pure grade
chemical and reagents were obtained locally. EDN1 was purchased from
Calbiochem (San Diego, CA).
The following hormonal preparations were administered via i.m. injection:
GnRH analogue (Receptal; Hoechst-Roussel Vet, Milan, Italy), eCG (Folligon;
Intervet, Milan, Italy), and the PGF2a analogue alfaprostol (Gabbrostim;
Centralvet, Milan, Italy).
Animals, Hormonal Regimen, and Tissue Collection
The protocols involving the use of the animals in these experiments were
approved by the Bioethics Committee of the University of Perugia. Unmated
New Zealand White rabbits of 5 mo of age and weighing 3.5–3.8 kg were
caged individually in quarters at the University of Perugia Central Animal
Facility and maintained under controlled conditions of 14L:10D and 188C. The
animals were provided with commercial rabbit chow and tap water ad libitum.
All rabbits were treated with 20 IU eCG, followed 3 days later by i.m. injection
of 0.8 lg GnRH (Day 0) to induce pseudopregnancy [33]. The rabbits were
maintained in accordance with the standards of animal care.
On Day 4 or Day 9 of pseudopregnancy, rabbits (n ¼ 18/group) were
administered i.m. 200 lg alfaprostol. At each luteal stage, three rabbits were
killed by cervical dislocation just before (time 0) and then 1.5, 3, 6, 12, and 24
h after PGF2a analogue administration. Reproductive tracts, which were
promptly removed from each animal, were thoroughly washed with saline. For
the analyses of luteal gene expression by RT-PCR, the CL were excised from
ovaries and after careful dissection of nonluteal tissue using fine forceps under
stereoscopic magnification, the specimens were rinsed with RNAse-free PBS
and immediately frozen at 808C. For the in vitro study, CL were harvested
from three does that were killed on Days 4 and 9 of pseudopregnancy, as
previously reported [31].
For the purpose of the present study, functional luteolysis was defined as a
50% drop in plasma progesterone relative to the pretreatment values, while
complete luteolysis was judged to be the failure of CL to secrete progesterone,
such that the levels of progesterone in the blood fell below 1.0 ng/ml, which is
the concentration detected in estrus rabbits [34].
Immunohistochemistry of EDN1
For the immunohistochemical detection of EDN1, two additional animals
for each time-point were killed just prior (time 0) to alfaprostol injection and
1.5 h and 3 h after alfaprostol injection administered on either Day 4 or Day 9
of pseudopregnancy. The ovaries were immediately excised, fixed by
immersion in 4% (v/v) formaldehyde in PBS (pH 7.4) for 24 h at room
temperature, and subsequently processed for embedding in paraffin following
routine tissue preparation procedures. Serial 7-lm-thick sections mounted on
poly-L-lysine-coated glass slides were dewaxed in xylene and hydrated through
a graded ethanol series. The sections were microwave irradiated for 5 min at
750 W in 10 mM citric acid buffer (pH 6.0) for antigen retrieval. All subsequent
steps were carried out in a moist chamber at room temperature. The sections
were first treated with a 0.5% solution of hydrogen peroxide in methanol for 10
min, in order to inactivate the endogenous pseudoperoxidase activity, then
rinsed with PBS and incubated for 30 min with normal goat serum, to minimize
the nonspecific binding of reagent in the subsequent steps. To reduce variability
in staining, within each luteal stage, all the tissue sections were incubated
together. The monoclonal mouse anti-EDN1 antibody was raised against a
peptide that maps within an internal region of human EDN1, which shows
100% amino acid sequence homology with the same region in the rabbit EDN1.
The primary antiserum was diluted 1:100 in PBS and added to the sections
overnight. The next day, the sections were washed in PBS and incubated with a
biotinylated secondary antibody (1:200 in PBS) for 30 min. After PBS washes,
the sections were exposed to avidin-biotin-peroxidase complex (1:2500 in PBS)
for 30 min, followed by the chromogen DAB for 5 min, to visualize the site of
reaction. The slides were then washed in PBS, counterstained with Gill’s
hematoxylin, and dehydrated before mounting in Canada balsam natural.
Positive reactions were recognized as reddish brown precipitates. Sections for
which the primary antibody was omitted or substituted by preimmune goat c-
globulin were used as negative controls for nonspecific staining.
RNA Extraction and Reverse-Transcription Multiplex
RT-PCR Amplification
For each rabbit, total RNA was extracted from a pool of eight CL
(approximately 90 mg of tissue) and reverse-transcribed into cDNA, while
multiplex PCR amplification was carried out with EDN1, EDNRA, EDNRB,
and 18S sense and antisense primers, as reported elsewhere [16]. The primer
sequences for ACE (168-bp product) were: forward, 5 0-CCTCTACCT-
GAACCTGC-30 and reverse, 50-TGGGCTTGTCTGGAAAGG-30. Preliminary
experiments were carried out to establish the optimal ratio of 18S primers to
their competimers, i.e., primers that were modified only at their 30-ends to
block extension by DNA polymerase, to be used in the reaction mix. The ratios
were 2:8 for EDN1 and ACE and 3:7 for EDNRA and EDNRB RT-PCRs,
respectively. The 18S rRNA is an ideal internal control for quantitative RNA
analysis because its expression remains invariant across tissues and treatments,
whereas its relatively high abundance makes it difficult to use in RT-PCR
experiments, in which target mRNA genes are far less abundant. However, by
mixing the appropriate amounts of 18S primers with their competimers, the
PCR amplification efficiency of 18S cDNA can be reduced to a level that is
roughly similar to that of the gene under study. Between 30 and 40 cycles, both
the target and 18S products were in a linear exponential phase of amplification
(data not shown). All the PCR reactions consisted of an initial denaturation step
at 948C for 75 sec, followed by amplification for 35 cycles of 948C for 15 sec,
608C for 30 sec, and 728C for 45 sec, with a final extension step of 728C for 10
min. Within each experiment and for each gene analyzed, the complete set of
samples was processed in parallel in a single PCR, using aliquots of the same
PCR master mix. The amplified PCR-generated products were analyzed by
electrophoresis on 2% agarose gels using ethidium bromide staining for
visualization. The analysis of amplification products was carried out as reported
elsewhere [16].
In Vivo Induction of Luteolysis
EDN1 was dissolved in saline at a concentration of 10 lg/ml and
administered i.v. via a catheter inserted in the central ear vein, as previously
reported [16]. The ACE inhibitor captopril was dissolved in saline at a
concentration of 5 mg/ml and injected s.c. (1 mg/kg) 1 h before EDN1 or
PGF2a analogue administration and again 8 h later. Both the dosage and
treatment protocols for captopril were based on the recently published
experimental data for cows [18].
On Day 9 of pseudopregnancy, rabbits (n ¼ 5 per group) were randomly
assigned to receive one of the following treatments: saline (control), EDN1 (10
lg), EDN1 plus ACE inhibitor, alfaprostol (100 lg), and alfaprostol plus ACE
inhibitor.
From each rabbit, blood samples were collected by venopuncture of the
marginal ear vein just before (basal) and 2, 4, 8, 24, and 48 h after treatment.
The samples, which were collected in EDTA-containing tubes, were
immediately centrifuged at 3000 3 g for 15 min, and the plasma was stored
frozen until assayed for progesterone concentration, to assess CL functional
status.
In Vitro Incubations
For the in vitro study, Day-4 or Day-9 CL were randomly distributed (one
CL/well) into incubation wells in 1 ml of culture medium 199 with EBSS that
contained 2.2 mg/ml sodium bicarbonate, 2.3 mg Hepes, and 3% BSA, referred
to here as M199. Before treatment, CL were placed inside each well using fine
forceps. Each incubation set of wells was divided into five experimental groups
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of five wells as follows: (I) medium alone as control; (II) EDN1 (100 lM); (III)
EDN1 plus PLA
2
inhibitor (100 nM); (IV) EDN1 plus PLC inhibitor (100 nM);
and (V) EDN1 plus PKC inhibitor (100 nM). The culture plates were incubated
at 378C in air with 5% CO
2
as reported elsewhere [16]. The medium in each
well was collected after 4 h of incubation and stored immediately at208C for
later determinations of progesterone and PGF2a. Each CL was weighed and
stored immediately at 208C for later determinations of NOS activity and
protein concentration. Preliminary evidence, together with the previous results
[16], guided our choices of incubation conditions and the minimum effective
dosages of the substances used in the present in vivo study (data not shown).
Progesterone and PGF2a Assays
Progesterone and PGF2a concentrations were determined by RIA with
specific antibodies, according to the procedures reported elsewhere [32]. The
assay sensitivity was 0.08 ng/ml for progesterone and 19 pg/ml for PGF2a. The
intraassay and interassay coefficients of variation were 5.3% and 10.2% for
progesterone and 8% and 12% for PGF2a, respectively.
NO Synthase Activity Determination
In rabbit CL, NOS activity was determined by monitoring the conversion of
[3H]L-arginine into [3H]L-citrulline using a commercial NOS assay kit
according to the procedure described previously [32].
Statistical Analysis
At each stage of pseudopregnancy, the ratios of each PCR product for the
target genes (EDN1, EDNRA, EDNRB, and ACE) normalized against the
coamplified 18S product were analyzed by two-way ANOVA (time after
alfaprostol treatment and gel being the two sources of variability) and the
Newman-Keuls multi-comparison post-test. Data relative to overall in vivo
treatment effects on plasma progesterone during the 48-h time-course of EDN1-
or PGF2a analogue-induced luteolysis were analyzed by ANOVA for repeated
measurements according to a model that included treatment group, doe within
group, time period, and interaction between group and time period; doe within
treatment was used as the error term. Progesterone, PGF2a, and enzyme
activity from the in vitro data were evaluated by ANOVA. All statistical
analyses were performed using Prism (GraphPad Software Inc., San Diego,
CA). Comparisons among all the data for days and time-points were evaluated
using the Student t-test. A value of P , 0.01 was considered significant.
RESULTS
EDN1 Immunolocalization in Rabbit CL
Using a monoclonal antibody, positive staining for EDN1
was localized in the endothelial cells of the luteal blood vessels
of ovaries collected before treatment on either Day 4 (Fig. 1d)
or Day 9 of pseudopregnancy (Fig. 2d). In the same
unstimulated ovaries, cytoplasmic positive signals were also
identified in the luteal (Figs. 1 and 2d) and granulosa cells of
the follicles (Figs. 1 and 2f), as well as in the ovarian epithelial
cells (Figs. 1 and 2e). In each positive cell type, staining was
evident 3 h after PGF2a analogue injection independently of
luteal stage (Figs. 1 and 2, g–i) and thereafter (data not shown).
Staining was completely abolished when the primary antibody
was substituted with nonimmune serum (Figs. 1 and 2, a–c).
Luteal Gene Expression
The corresponding amplification products obtained using
primers designed for each gene matched the expected sizes
(Figs. 3–6, panels B and C).
EDN1 mRNA. Prior to treatment, the relative abundances of
EDN1 mRNA did not differ between Day-4 and Day-9 CL
(Fig. 3A). At Day 4 of pseudopregnancy, the luteal EDN1
mRNA levels rose two-fold (P  0.01) 1.5 h after alfaprostol
treatment, and remained at approximately the same high levels
(P  0.01) for the following 24 h (Fig. 3A). At Day 9 of
pseudopregnancy, the numbers of EDN1 mRNA luteal
transcript were increased (P  0.01) 1.5 h and 3 h after
PGF2a analogue challenge (Fig. 3A). Thereafter, the numbers
of EDN1 transcript dropped (P  0.01) to the pretreatment
values (Fig. 3A).
EDNRA and EDNRB mRNAs. Before treatment, both the
EDNRA (Fig. 4A) and EDNRB (Fig. 5A) mRNA transcripts
were poorly expressed in Day-4 CL compared to Day-9 CL (P
 0.01). Upon alfaprostol administration at Day 4 of
pseudopregnancy, both the EDNRA and EDNRB mRNA levels
FIG. 1. Cellular immunolocalization of
EDN1 in rabbit ovaries collected on Day 4
of pseudopregnancy before (d–f) and 3 h (g–
i) after PGF2a analogue (alfaprostol) injec-
tion, showing positive staining in luteal cells
(lc), endothelial cells (en), ovarian epitheli-
um (ep), and granulosa cells of follicles (gc).
Control sections (a–c) incubated in the
absence of primary antibody show no
reactivities in the lc, en, ep, and gc.
Bar ¼ 20 lm.
158 BOITI ET AL.
were increased (P  0.01) two- to three-fold, and remained
high (P  0.01) for the following 24 h (Figs. 4 and 5A).
Conversely, at Day 9 of pseudopregnancy, the luteal EDNRA
and EDNRB genes did not show any clear patterns, remaining
at approximately the same levels for up to 24 h after PGF2a
analogue challenge (Figs. 4 and 5A).
ACE mRNA. Before treatment, the steady-state level of ACE
mRNA was lower (P  0.01) at Day 4 than at Day 9 of
pseudopregnancy (Fig. 6A). At Day 4, the ACE mRNA levels
rose almost two-fold (P  0.01) within the first 1.5 h after
alfaprostol administration and remained at approximately the
same relatively high levels (P  0.01) for the following 24 h
(Fig. 6A). Conversely, at Day 9 of pseudopregnancy, the
relative abundance of ACE mRNA increased (P  0.01) 1.5 h
after alfaprostol challenge, but then declined to basal values
during the course of luteal regression (Fig. 6A).
In Vitro Culturing of CL
For Day-9 CL cultured in vitro, EDN1 decreased (P  0.01)
progesterone release (Fig. 7A) but increased (P  0.01) PGF2a
secretion (Fig. 7B) and NOS activity (Fig. 7C). Coincubation
of EDN1 with the PLA
2
-inhibitor did not modify the EDN1-
FIG. 2. Cellular immunolocalization of
EDN1 in rabbit ovaries collected on Day 9
of pseudopregnancy before (d–f) and 3 h (g–
i) after PGF2a analogue (alfaprostol) injec-
tion, showing positive staining in luteal cells
(lc), endothelial cells (en), ovarian epitheli-
um (ep), and granulosa cells of follicles (gc).
Control sections (a–c) incubated in the
absence of primary antibody show no
reactivities in the lc, en, ep, and gc.
Bar ¼ 20 lm.
FIG. 3. Gene expression patterns of EDN1 mRNAs in CL of rabbits collected 0, 1.5, 3, 6, 12, and 24 h after PGF2a analogue (alfaprostol) injection on
Day 4 or Day 9 of pseudopregnancy. A) Summarized data (means 6 SEM) derived from densitometric analyses of EDN1 in CL, reported in arbitrary units
relative to 18S expression. For each day of pseudopregnancy and for each time-point, the values shown represent the combined results for three different
rabbits. Different letters above the bars indicate significantly different values (P , 0.01) among treatment days and time-points. B, C) Representative
photographs (Day 4, B; Day 9, C) of typical 2% agarose, ethidium bromide-stained gels, showing the presence of the expected products yielded after RT-
PCR using primers for the target EDN1 and 18S. Lane LD shows the kilobase DNA marker, lane PCR represents a negative control of RNA that was not
reverse-transcribed but was subjected to PCR amplification, while the other lanes represent samples taken at the corresponding hours after alfaprostol
injection.
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dependent effects either on hormone or NOS activity (Fig. 7).
Conversely, the addition of either PLC or PKC inhibitors
blocked the luteolytic action of EDN1 on both progesterone
and PGF2a release, as well as on NOS activity, all of which
remained at control values (Fig. 7). In Day-4 CL, EDN1 did
not cause any changes among the experimental groups in terms
of hormone release and enzyme activity (data not shown).
In Vivo Induction of Luteolysis
The plasma P4 concentrations, which are used as a marker
of luteal functional activity, decreased similarly in rabbits 8 h
after EDN1 or alfaprostol injection on Day 9 of pseudopreg-
nancy, and complete functional luteolysis was achieved 24 h
later when the plasma P4 levels dropped to 0.3 ng/ml in both
groups (Fig. 8). EDN1-induced functional luteolysis was
blocked by pretreatment with the ACE inhibitor captopril
(Fig. 8). Conversely, alfaprostol-induced luteolysis was not
affected by cotreatment with captopril (Fig. 8).
DISCUSSION
The present study provides evidence that exogenous PGF2a
differentially modulates the expression of EDN1, its receptors,
and ACE in both the early luteal- and midluteal-phase CL of
pseudopregnant rabbits. However, only in the latter, which
have acquired luteolytic competence, does a positive and
reciprocal feed-back mechanism exist between PGF2a and
EDN1, likely mediated by ACE, come into play to induce
functional and structural luteolysis.
FIG. 4. Gene expression patterns of EDNRA mRNAs in CL of rabbits collected 0, 1.5, 3, 6, 12, and 24 h after PGF2a analogue (alfaprostol) injection on
Day 4 or Day 9 of pseudopregnancy. A) Summarized data (means6 SEM) derived from densitometric analyses of EDNRA in CL, reported in arbitrary units
relative to 18S expression. For each day of pseudopregnancy and for each time-point, the values shown represent the combined results for three different
rabbits. Different letters above the bars indicate significantly different values (P , 0.01) among days and time-points. B, C) Representative photographs
(Day 4, B; Day 9, C) of typical 2% agarose, ethidium bromide-stained gels, showing the presence of the expected products yielded after RT-PCR using
primers for the target EDNRA and 18S. Lane LD shows the kilobase DNA marker, lane PCR represents a negative control of RNA that was not reverse-
transcribed but was subjected to PCR amplification, while the other lanes represent samples taken at the corresponding hours after alfaprostol injection.
FIG. 5. Gene expression patterns of EDNRB mRNAs in the CL of rabbits collected 0, 1.5, 3, 6, 12, and 24 h after PGF2a analogue (alfaprostol) injection
on Day 4 or Day 9 of pseudopregnancy. A) Summarized data (means 6 SEM) derived from densitometric analyses of EDNRB in CL, reported in arbitrary
units relative to 18S expression. For each day of pseudopregnancy and for each time-point, the values shown represent the combined results for three
different rabbits. Different letters above the bars indicate significantly different values (P , 0.01) among days and time-points. B, C) Representative
photographs (Day 4, B; Day 9, C) of typical 2% agarose, ethidium bromide-stained gels, showing the presence of the expected products yielded after RT-
PCR using primers for the target EDNRB and 18S. Lane LD shows the kilobase DNA marker, lane PCR represents a negative control of RNA that was not
reverse-transcribed but was subjected to PCR amplification, while the other lanes represent samples taken at the corresponding hours after alfaprostol
injection.
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The cell-type distribution of EDN1 within the rabbit ovary
was precisely identified by the IHC technique. Independently
of the luteal stage examined, either before or after PGF2a
treatment, EDN1 staining was clearly evidenced in the vascular
endothelial and luteal cells of the CL. In contrast, Schams et al.
[18], using the IHC technique on bovine midcycle CL, revealed
no or only very weak staining for EDN1 in both endothelial
and steroidogenic cells, before and up to 4 h after PGF2a
injection. This discrepancy is likely due to interspecies
differences and/or to methodological causes rather than to the
specificity of the primary antibody used. In fact, the mature
forms of EDN1 are highly conserved among species, and the
rabbit EDN1 nucleotide sequence is identical to that of human,
porcine, rat, bovine, and canine origin [35]. In the present
study, positive immunoreactivity for EDN1 was evidenced in
the cytoplasm of follicular granulosa cells, as previously found
for other species [36–40], and in the ovarian surface epithelial
cells, which are the sites of an inflammatory-like response
during ovulation [41, 42].
Before treatment, the relative abundance of EDN1 mRNA
was comparable between young and mature CL, whereas those
of the EDNRA, EDNRB, and ACE mRNAs were much lower in
Day 4 than in Day 9 CL. These results confirm that all the
EDN1 system members and ACE are constitutively expressed,
albeit at different levels, in rabbit CL, as reported in other
species [43]. These differences may reflect developmental
changes in the ratio between steroidogenic and endothelial cell
compartments over the total cell population of rabbit CL [44]
or in their gene expression levels. Subtle differences in the
intraovarian hormonal milieu during the luteal growing phase
[11] could also be responsible for the discrepancy with the
previous report [16] in terms of the relative abundances of
EDN1 and EDNRB transcripts in Day-4 CL.
In the present study, exogenous PGF2a analogue challenge
clearly up-regulated the transcription of both the EDN1 and
ACE genes, independently of luteal stage and well in advance
of progesterone decline [45]. Interestingly, whereas the
expression levels of these mRNAs remained high and quite
FIG. 6. Gene expression patterns of ACE mRNAs in the CL of rabbits collected 0, 1.5, 3, 6, 12, and 24 h after PGF2a analogue (alfaprostol) injection on
Day 4 or Day 9 of pseudopregnancy. A) Summarized data (means 6 SEM) derived from densitometric analyses of ACE in CL, reported in arbitrary units
relative to 18S expression. For each day of pseudopregnancy and for each time-point, he values shown represent the combined results for three different
rabbits. Different letters above the bars indicate significantly different values (P  0.01) among days and time-points. B, C) Representative photographs of
typical 2% agarose, ethidium-bromide stained gels, showing the presence of the expected products yielded after RT-PCR using primers for the target ACE
(168 bp) and 18S (489 bp). Lane LD shows the kilobase DNA marker, lane PCR represents a negative control of RNA that was not reverse-transcribed but
was subjected to PCR amplification, while the other lanes represent samples taken at the corresponding hours after alfaprostol injection.
FIG. 7. In vitro effects of medium alone, endothelin 1 (EDN1), EDN1 plus PLA2 inhibitor, EDN1 plus PLC inhibitor, and EDN1 plus PKC inhibitor on
both progesterone (A) and PGF2a (B) release, and total NOS activity (C) by rabbit CL harvested on Day 9 of pseudopregnancy. The results shown are the
means 6 SD of five replicates. Different letters above the bars indicate significantly different values (P  0.01).
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stable in young CL for the 24 h following PGF2a treatment, in
mature CL they were up-regulated only for the first 1.5–3 h.
PGF2a up-regulated both the EDNRA and EDNRB genes in the
early-stage CL, whereas no modulation was evident in the
midluteal-stage CL, probably because they were already being
expressed at their maximal levels. On the other hand, the basal
EDNRA and EDNRB mRNA levels in the midluteal CL were
similar to those induced by PGF2a in the early luteal CL. The
EDN1, EDNRA, EDNRB, and ACE expression differences
suggest that the luteal cell components of growing and mature
CL react differently to the same dosage of exogenous PGF2a,
which supports the idea of a functional role for the RAS/EDN1
system in the luteolytic cascade evoked by PGF2a. However, it
remains to be established whether the stimulatory action of
PGF2a on the rabbit CL EDN1 gene is exerted directly or
indirectly, given that in bovine carotid artery endothelial cells,
ANGII immediately and dose-dependently up-regulates the
expression of preproendothelin 1 mRNA [46]. However, the
insensitivity of CL to the luteolytic action of PGF2a in the
early luteal stage cannot be ascribed to a faulty response of the
local EDN1/RAS system activation, but rather to some other
mechanism, including the lack of endogenous PGF2a produc-
tion which modulates CL function, as previously indicated for
other species [47, 48] and for rabbits [49].
PGF2a-induced EDN1 gene expression increases have also
been observed in midluteal-phase CL of cycling ewes [15] and
cows [10, 11, 18, 50, 51], but not in early luteal-phase bovine
CL [11, 52]. In cattle, PGF2a injection rapidly increases EDN1
release within the regressing CL, as well as into the ovarian
venous blood [53]. Furthermore, the regulatory mechanisms
that control the expression of ACE have been demonstrated in
bovine CL during the estrus cycle and after the induction of
luteal regression, when luteal ACE mRNA expression increases
continuously, peaking 12 h and 24 h after PGF2a injection on
Days 8 and 12 of the estrus cycle [17, 18, 54]. Interestingly, in
cows, the overall response of CL EDN1 receptors to the
luteolytic challenge dose of PGF2a showed the opposite
pattern, since on Day 4 it failed to up-regulate EDNRA [11] but
was effective at up-regulating both subtypes for up to 48 h
when administered on Days 8–10 of the cycle. Thus, in contrast
to what has been found in cows [11, 52], the EDN1 system in
the CL of rabbits during the early luteal phase are not
completely refractory to PGF2a, even if it is not able to
decrease progesterone production.
Our in vitro results show that EDN1, after engagement of its
cognate binding site, likely EDNRA [16], activates the G
protein-dependent PLC/PKC pathway, which inhibits proges-
terone release and enhances PGF2a synthesis and NOS activity
in Day-9 CL. These data are in agreement with previous reports
on EDN1 intracellular signaling systems in other tissues [55,
56], as well as in ovine, bovine, and human luteal cells [15, 52,
57, 58]. In contrast, EDN1 did not affect the basal production
levels of progesterone and PGF2a or NOS activity in Day-4
CL, in agreement with our previous results obtained in vivo
[16]. These findings can be justified by the relatively low levels
of receptors for EDN1, as compared to those present in Day-9
CL; alternatively, they can be explained by changes in the
EDN1 intracellular signaling pathways, rather than to reduced
or impaired synthesis of EDN1, since PGF2a up-regulates its
expression. In bovine CL, Choudhary et al. [59] found that the
luteolytic efficacy of EDN1 was the same on Days 4 and 10,
suggesting that this vasoactive agent is a tonic inhibitor of
progesterone production rather than a mediator of PGF2a
action. These contrasting findings suggest that the mechanism
of acquisition of luteolytic competence is different in rabbit and
bovine CL.
In the present study, we have shown that EDN1-induced
luteolysis at Day 9 of pseudopregnancy is inhibited by
antagonizing ACE with captopril. Previously, we found that
the luteolytic action of EDN1 was also blocked by pretreatment
with indomethacin, a cyclooxygenase inhibitor [16]. Taken
together, these findings further support the putative role of the
RAS/EDN1 system in the luteolytic process, which is probably
also mediated by the prostanoid pathway in the rabbit, similar
to what has been described in cows [18, 23, 60]. However, our
present data show that PGF2a-induced luteolysis is not
affected by the blockade of ACE, which confirms that, at least
in the pseudopregnant rabbit model, the cascade mechanism
triggered by the prostaglandin analogue alfaprostol does not
require the RAS system for the stimulation of luteolysis, in
accordance with previous results obtained for the cow [18].
The findings of the present study, together with the results
of previous studies conducted by us [16] and others [48, 61,
62], suggest that in midluteal-phase CL of pseudopregnant
rabbits, positive reciprocal feedback mechanisms exist between
RAS/EDN1 and PGF2a, which are capable of inducing
functional and structural luteolysis. With a short time-lag,
exogenous PGF2a stimulates endothelial and luteal cells to
express increasing levels of EDN1 transcripts. EDN1, via
autocrine and paracrine mechanisms, engages luteal EDNRA
receptors and stimulates, through ACE mediation, the intra-
luteal synthesis of new PGF2a, which in turn binds to its luteal
FP receptors and up-regulates EDN1 expression in both
endothelial and luteal cells in both paracrine and autocrine
FIG. 8. In vivo effects of EDN1 (10 lg) and
EDN1 plus ACE inhibitor (captopril, 1 mg/
kg s.c. given twice) (left panel), and PGF2a
analogue (alfaprostol, 100 lg) and PGF2a
plus captopril (right panel) on progesterone
plasma levels at Day 9 of pseudopregnancy.
Values are mean 6 SEM for 5 animals/
group. *, P  0.01 compared to the control
(saline).
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fashions. Although the present data add new pieces to the
biological puzzle of luteolysis in the rabbit model, further
studies are needed to improve our understanding of the system
of fine tuning that controls the CL life span in this species and
the differential, age-dependent resistance to the luteolytic
action of exogenous PGF2a.
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